RELMADA THERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Coral Gables, FL
SEC filing record 1 source field available
Fiscal year end
31 December
RELMADA THERAPEUTICS, INC. has filed 603 SEC EDGAR filings since 13 Nov 2012

SEC filing history

Showing 176-200 of 603 matching filings.

Per page
25
Current page
8
3

OWNERSHIP DOCUMENT

Filing date
13 Jan 2023
Reporting date
12 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Jan 2023
Reporting date
06 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Jan 2023
Reporting date
06 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
09 Jan 2023
Reporting date
09 Jan 2023
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
05 Jan 2023
Reporting date
01 Jan 2023
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
28 Dec 2022
Reporting date
27 Dec 2022
Next action
Verify source filing
4

4 filing

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88207

SC 13G filing

Filing date
20 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Dec 2022
Reporting date
08 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
07 Dec 2022
Reporting date
07 Dec 2022
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
14 Nov 2022
Reporting date
11 Nov 2022
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
10 Nov 2022
Reporting date
10 Nov 2022
Next action
Verify source filing
10-Q File 001-39082

QUARTERLY REPORT

Filing date
10 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
SC 13G File 005-88207

SC 13G filing

Filing date
21 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88207

RELMADA THERAPEUTICS, INC.

Filing date
17 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88207

SCHEDULE 13G

Filing date
17 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .